... A web-based Atlas of Patient-Derived Xenografts of cancer patients:A resource of MURAL PDX data
Home
Search by IDs Search by Gene
Browse
With gene expression Without gene expression Mutation & CNV Plot
Patient Tumor & Clinical details PDX & PDXBiomarker details
View & Update
Statistics



PDX model details

PDX ID 472M Cx
Host Strain(and Source) NSG
Source: Monash University
Host Strain Immune system Humanized NO
Host Type Castrate
Graft Site Subcutaneous
Current Generation
(* indicates number of generations grown in Castrate host)
 10 (5*)
Average PDX Generation Time (days +/- SEM) 51 ± 3
Tumor preparation Tumor solid
Tumor Characterization Technology Histology, IHC, STR profiling, targeted DNA sequencing, RNAseq
Tumor confirmed not to be of Mouse/EBV origin Yes; negative for CD45 and/or positive for human CK8/18 and/or human mitochondria by IHC
Passage QA performed Routine QA every 2-3 passages
Associated meta data
PDX model availability Yes (fixed, frozen)
Governance restriction for distribution Available to investigators with appropriate ethics approvals, approved EOI from MURAL committee, and material transfer agreements
Pubmed ID 34413304
Markers 472M Cx
AR N
PSA N
PSMA N
NE Y
ERG N
This heatmap displays the call type of curated CNVs in the presented samples.
This heatmap displays the call type of CNVs in commonly occurred samples.

PDX ID Gene Symbol CNV Log2 CNV Copy CNV Call Experiments name Platform Reference genome
472M Cx RB1 -25.4079 0.0000000449 homdel MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
472M Cx PTEN -2.22538 0.427685 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
472M Cx NCOR1 -1.29767 0.813565 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
472M Cx CDH1 -1.29048 0.81763 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
472M Cx ZFHX3 -1.29048 0.81763 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
472M Cx FANCA -1.29048 0.81763 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
472M Cx BRCA1 -1.26655 0.831305 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
472M Cx TP53 -1.20961 0.864771 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
472M Cx CHD7 0.53139 2.89064 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19

Clinical Information

Sample Number 472M
Sample Site Left ilium
Sample source Biopsy
Pathology Tumor Diagnosis None
Gleason Score None
Primary Gleason Score None
Secondary Gleason Score None
Tertiary Gleason Score None
ISUP Grade Group
Tumor Grade
D'Amico Risk Classification
Tumor Volume (in cc) 0.0
Treatment Prior to Specimen Collection ADT, docetaxel

Patient Information

Patient Number 472
Sex Male
Diagnosis Prostate Cancer
PSA at diagnosis (ng/mL) 630
Consent to share data

Patient Tumor Collection (Current Model)
Tumour sample ID 472M
Patient Age (binned in 5 year age groups) 50-54
This heatmap displays the mutations of curated sequence variants.
Download The Mut plot is not shown
PDX ID Gene Symbol Depth ALT_FREQ Consequence Exon GnomAD_AF CADD_PHRED Clinvar_clnsig Platform Experiments Name Reference Library Type Instrument Type
472M Cx SRC 535 0.68 missense_variant '12/14 8.15E-06 25.1 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
472M Cx GPR158 736 0.58 stop_gained '11/11 8.19E-06 36 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
472M Cx CTNNB1 526 0.57 missense_variant '3/15 4.07E-06 28.6 Pathogenic/Likely_pathogenic,_other Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500